Home pageABUS • NASDAQ
add
Arbutus Biopharma Corp
Chiusura precedente
4,39 $
Intervallo giornaliero
3,87 $ - 4,42 $
Intervallo annuale
2,71 $ - 5,10 $
Cap di mercato
766,41 Mln USD
Volume medio
1,59 Mln
Rapporto P/E
-
Dividendo/Prezzo
-
Borsa valori principale
NASDAQ
Notizie
Informazioni
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Fondazione
2007
Sito web
Dipendenti
44
